Optimizing Outcomes in Osteoporosis Management: How Can the Pharmacist Help? (Case 1)

Published Online: Monday, June 6, 2011
Follow Pharmacy_Times:
Pharmacy Times Office of Continuing Professional Education

Optimizing Outcomes in Osteoporosis Management: How Can the Pharmacist Help? (Case 1)

Jennifer M. Malinowski, PharmD, RPh, Associate Professor, Pharmacy Practice, Wilkes University School of Pharmacy

Despite the fact that women of all races and ethnicities are at risk for developing osteoporosis, the condition is often underdiagnosed and undertreated. Pharmacists have a unique opportunity to address this need. This case study activity is designed to provide pharmacists with an update on screening methods, and current nonpharmacologic and over-the-counter treatment options for patients at risk for and those diagnosed with postmenopausal osteoporosis. It will also discuss the incidence, prevalence, and burden of postmenopausal osteoporosis, along with risk factors for the development of osteoporosis.

Educational Objectives

Upon completion of this educational activity, participants should be able to:
  • Describe the incidence, prevalence, and burden of postmenopausal osteoporosis and recognize the risk factors for osteoporosis.
  • Explain the pathophysiologic and metabolic basis for low bone density and osteoporosis.
  • Discuss the screening methods and current nonpharmacologic and over-the-counter treatment options for patients at risk for and those diagnosed with postmenopausal osteoporosis.

Credits: 1.0
Expiration date: May 15, 2013

Click here to view this lesson.
Related Articles
A former pharmacy technician thought the prescription pill records she was finagling were better shred than read.
A pharmacist testified before a Senate subcommittee today that unprecedented price hikes for formerly inexpensive generic prescription drugs are “wreaking havoc” on the health care system while jeopardizing the viability of community pharmacies.
After the Drug Enforcement Administration revoked the Tampa-based pharmacy’s registration to sell controlled substances and seized its drugs, the company fought back with a lawsuit.
Latest Issues
$auto_registration$